Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · Real-Time Price · USD
5.00
-0.05 (-0.99%)
At close: Nov 12, 2026, 4:00 PM EST
5.00
0.00 (0.00%)
After-hours: Nov 12, 2026, 4:17 PM EST
POCI Market Cap
POCI has a market cap or net worth of $54.86 million as of November 12, 2026. It is the 29,182nd most valuable company in the world and the 4,496th biggest in the United States. Its market cap has increased by 43.25% in one year.
Market Cap
54.86M
Enterprise Value
49.08M
1-Year Change
43.25%
Global Rank
Country Rank
#4,496 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, POCI's market cap has increased from $6.70M to $54.86M, an increase of 718.87%. That is a compound annual growth rate of 7.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 54.86M | 69.86% |
| Dec 31, 2025 | 32.30M | 5.56% |
| Dec 31, 2024 | 30.60M | -16.16% |
| Dec 29, 2023 | 36.50M | 16.24% |
| Dec 30, 2022 | 31.40M | -21.70% |
| Dec 31, 2021 | 40.10M | 102.53% |
| Dec 31, 2020 | 19.80M | -14.66% |
| Dec 31, 2019 | 23.20M | 44.10% |
| Dec 31, 2018 | 16.10M | 292.68% |
| Dec 29, 2017 | 4.10M | -6.82% |
| Dec 30, 2016 | 4.40M | -12.00% |
| Dec 31, 2015 | 5.00M | 31.58% |
| Dec 31, 2014 | 3.80M | -5.00% |
| Dec 31, 2013 | 4.00M | 17.65% |
| Dec 31, 2012 | 3.40M | 100.00% |
| Dec 30, 2011 | 1.70M | 750.00% |
| Dec 31, 2010 | 200.00K | -81.82% |
| Dec 31, 2009 | 1.10M | 450.00% |
| Dec 31, 2008 | 200.00K | -94.44% |
| Dec 31, 2007 | 3.60M | -35.71% |
| Dec 29, 2006 | 5.60M | 124.00% |
| Dec 30, 2005 | 2.50M | -71.26% |
| Dec 31, 2004 | 8.70M | 135.14% |
| Dec 31, 2003 | 3.70M | 42.31% |
| Dec 31, 2002 | 2.60M | -65.79% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Utah Medical Products | 233.05M |
| Pro-Dex | 224.96M |
| KORU Medical Systems | 174.37M |
| Anbio Biotechnology | 171.61M |
| Stereotaxis | 86.23M |
| Daxor | 49.16M |
| Harvard Bioscience | 45.08M |
| Nephros | 34.36M |